Cristine Delnevo, a prominent figure in the field, is the subject of translation.
Cristine Delnevo, the Director of the Rutgers Tobacco Research Center and a Professor of Health Behavior, Society, and Policy at Rutgers School of Public Health, has been appointed as the Chair of the Tobacco Products Scientific Advisory Committee (TPSAC) by the U.S. Food and Drug Administration (FDA). Her tenure will last until January 31, 2025.
In March 2021, Delnevo was appointed as a member of the Tobacco Products Scientific Advisory Committee (TPSAC). TPSAC was established in 2009 to review and evaluate safety, dependence, and health issues related to tobacco products and provide recommendations, information, and advice to the FDA Commissioner. Committee members are chosen by the FDA Commissioner from individuals with medical, medical ethics, scientific, or technical expertise related to the manufacturing, evaluation, or use of tobacco products.
Delnevo stated in a press release issued by Rutgers, "Since the signing of the Family Smoking Prevention and Tobacco Control Act in 2009, I have placed great importance on the FDA's advisory committees. As mandated by the Tobacco Control Act, these committees play an important role in several areas, perhaps most notably in the review of modified risk tobacco products.
Delnevo's expertise covers tobacco behavior trends at the population level, particularly in non-cigarette tobacco products such as cigars and electronic cigarettes, tobacco control policies and regulations, and research methods for surveys.
Statement:
This article is compiled from third-party information and is only intended for industry exchange and learning.
This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is only for industry exchange and research purposes.
Due to limitations in the level of translation, the translated article may not accurately convey the original meaning. Please refer to the original text for the most accurate version.
2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau or Taiwan-related, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
